The pros and cons of buying Woolworths shares this month

Is this the right time to invest in the supermarket stock?

| More on:
A couple in a supermarket laugh as they discuss which fruits and vegetables to buy

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Woolworths Group Ltd (ASX: WOW) shares have dropped close to 20% since 28 August 2024, as the chart below shows. When a defensive ASX share falls that far, it can be a good idea to consider if the business is a buy-the-dip opportunity.

The business has suffered from a number of different issues such as slowing food inflation, political scrutiny and a strike impacting the company's supply chain.

Woolworths is also facing economic challenges in some of its businesses, particularly BIG W, which is hurting profit growth.

Below, I'll share my view on Woolworths shares.  

Pros

While Woolworths experienced difficulties in its Australian food business, it managed to grow sales in every single division in the first half of FY25.

Australian food sales rose 2.7% to $26.7 million, Australian business-to-business sales increased 5.5%, New Zealand sales grew 2.7% (in New Zealand dollar terms), and W Living sales grew 16.1%.

While the supply chain strike was painful, it was a one-off that the company has hopefully recovered from by now. It should be able to report stronger growth in the HY26 result and FY26 result as its comparative period will include the weaker, disrupted HY25 result.

There are a number of growth areas within the business, helping offset some of the headwinds experienced by the Australian food division, though they are starting from a small base.

Group e-commerce growth was 18.3%, with strong 'same-day' and 'on-demand' growth in the first half through a convenience proposition and Milkrun expansion.

It also said that it has expanded the Woolworths MarketPlus with gross merchandise value (GMV) of $246 million, up 41.7% year over year. There are now over 400,000 items on the BIG W market.

According to the forecast on Commsec, Woolworths' share price is just 19x FY26's estimated earnings. That seems cheap to me.  

Cons on Woolworths shares

For starters, the major supermarkets are now facing a lot of political scrutiny. According to reporting by the ABC, Labor has said it will heavily fine price gouging by supermarkets, while the Coalition has suggested it could create divestiture powers to break up the Woolworths and Coles Group Ltd (ASX: COL) if they behave anti-competitively.

The second negative aspect of the business is that it's already a huge business with a significant national presence. I think the business can continue growing profit, but due to its size, it may be at a slower rate than in the past. However, its scale advantages enable stronger profit margins than if it were smaller.

Lastly, while it's great for households that inflation has reduced, it has lowered the sales growth rate for the Woolworths food business.

Overall, I think Woolworths shares do look appealing at this valuation. We all need to eat, so it's very defensive, and there's scope for profit to bounce back in the next few years.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Coles Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Consumer Staples & Discretionary Shares

Beef cattle in stockyard.
Consumer Staples & Discretionary Shares

Queensland floods to have a 'material' impact on this ASX agricultural stock's earnings

This company is likely to experience a material hit to earnings as a result of the floods in Queensland.

Read more »

A wine technician in overalls holds a glass of red wine up to the light and studies it.
Consumer Staples & Discretionary Shares

Treasury Wine shares keep the good times flowing

Brokers warn that the current lift is likely to be fragile.

Read more »

A man pushes a supermarket trolley with phone in hand down a supermarket aisle looking at the products on the shelves.
Consumer Staples & Discretionary Shares

Are Coles or Woolworths shares a better buy in 2026?

Which supermarket giant is the better buy this year?

Read more »

Young fruit picker clipping bunch of grapes in vineyard.
Consumer Staples & Discretionary Shares

Down over 50%, is this the ASX 200's greatest recovery share for 2026?

After a brutal year, Treasury Wine shares have been deeply sold off. Is a recovery starting to take shape for…

Read more »

A car dealer stands amid a selection of cars parked in a showroom.
Consumer Staples & Discretionary Shares

This ASX All Ords stock edges lower as investors digest key milestone

After completing a major acquisition, this ASX All Ords stock is back in focus as investors assess the next phase.

Read more »

A little boy surrounded by green grass and trees looks up at the sky, waiting for rain or sunshine.
Consumer Staples & Discretionary Shares

Why is Cobram Estate rocketing 17% today?

Cobram Estate shares jump 17% today after a broker upgrade and renewed confidence in its US growth plans.

Read more »

A young farnmer raise his arms to the sky as he stands in a lush field of wheat or farmland.
Consumer Staples & Discretionary Shares

These agricultural stocks are fundamentally undervalued, Bell Potter says

Bell Potter has named three stocks in the agricultural sector that it believes to be fundamentally undervalued.

Read more »

A baby's eyes open wide in surprise as it sucks on a milk bottle.
Consumer Staples & Discretionary Shares

Why this ASX small-cap share is back in focus after a US market update

A fresh US update has put Bubs shares back on investors’ radars as FDA approval moves closer and sales continue.

Read more »